LEP and metabolic dysfunction-associated steatohepatitis: Leptin, an adipokine produced in the liver and the adipose tissue, is thought to contribute, in part, to NASH development in obesity through its proinflammatory actions on sinusoidal epithelial cells and Kupffer cells [9–12].